Wednesday, 10 May 2017

AstraZeneca's asthma drug fails in study

(Reuters) - Drugmaker AstraZeneca Plc said its asthma drug failed to meet the main goal of significantly reducing the annual asthma exacerbation rate in a late-stage study.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)